156 results
8-K
OCUL
Ocular Therapeutix Inc
3 Jun 24
Cost Associated with Exit or Disposal Activities
9:15am
of approximately $1.0 to $2.0 million, which includes garden leave, severance benefits and related costs and which are expected to result in cash
8-K
EX-10.2
pir4pv
22 Feb 24
Ocular Therapeutix, Inc. Announces $325.0 Million Private Placement
7:34am
8-K
m2dumvmbr y9rl
22 Feb 24
Ocular Therapeutix, Inc. Announces $325.0 Million Private Placement
7:34am
8-K
EX-10.4
760gvt32ujegg 45
22 Feb 24
Ocular Therapeutix, Inc. Announces $325.0 Million Private Placement
7:34am
8-K
EX-10.3
pald6g
22 Feb 24
Ocular Therapeutix, Inc. Announces $325.0 Million Private Placement
7:34am
424B5
8c4 y9xr69fb3y
14 Dec 23
Prospectus supplement for primary offering
4:09pm
8-K
EX-1.1
x6yv y07sq9p01si855
14 Dec 23
Ocular TherapeutixTM Announces Pricing of Public Offering of Common Stock
8:46am
424B5
6bxy5dq13d0urqnyrc
13 Dec 23
Prospectus supplement for primary offering
4:10pm